Biophytis S.A. (0D1W.L)
| Previous close | 0.0931 |
| Open | 0.0900 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0832 - 0.0900 |
| 52-week range | 0.0832 - 0.0900 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 1.42 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2640 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- EQS Group
Biophytis announces the drawing of the second tranche of ORNANE under the 2021 Atlas Contract for €4 million
Biophytis / Key word(s): Miscellaneous Biophytis announces the drawing of the second tranche of ORNANE under the 2021 Atlas Contract for €4 million 30-Jun-2022 / 23:00 CET/CEST Biophytis announces the drawing of the second tranche of ORNANE under the 2021 Atlas Contract for €4 million Paris (France), Cambridge (Massachusetts, U.S.), June 30th, 2022, 11:00 pm CET – Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of the
- EQS Group
Biophytis presents the development of Sarconeos (BIO101) in Phase 3 for the treatment of Sarcopenia at the 15th SCWD International Congress
Biophytis / Key word(s): MiscellaneousBiophytis presents the development of Sarconeos (BIO101) in Phase 3 for the treatment of Sarcopenia at the 15th SCWD International Congress 27-Jun-2022 / 23:00 CET/CESTBiophytis presents the development of Sarconeos (BIO101) in Phase 3 for the treatment of Sarcopenia at the 15th SCWD International Congress Paris (France), Cambridge (Massachusetts, United States), June 27, 2022 – 11pm CET – Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophy
- EQS Group
Biophytis: Results of the Combined General Meeting on June 21, 2022 All ordinary and extraordinary resolutions presented by the company have been adopted
Biophytis / Key word(s): AGM/EGMBiophytis: Results of the Combined General Meeting on June 21, 2022 All ordinary and extraordinary resolutions presented by the company have been adopted 22-Jun-2022 / 23:00 CET/CEST Results of the Combined General Meeting on June 21, 2022 All ordinary and extraordinary resolutions presented by the company have been adopted Paris, France, Cambridge (Massachusetts, États-Unis), June 22, 2022 – 23h00 - Biophytis SA (Nasdaq CM : BPTS, Euronext Growth Paris : ALBPS),
